STYLAGE range (Vivacy) is marketed as CE Marked medical devices in applicable jurisdictions — verify local conformity/certificates with the authorised distributor.
Manufactured using Vivacy quality systems; sterile single Use packaging and traceability required for professional use.
STYLAGE range (Vivacy) is marketed as CE Marked medical devices in applicable jurisdictions — verify local conformity/certificates with the authorised distributor.
Manufactured using Vivacy quality systems; sterile single Use packaging and traceability required for professional use.
Dermal filler & skin revitalisation bundle
Description
Curated professional bundle combining volumising and hydrating STYLAGE products to address facial volume loss and skin quality. The bundle pairs deep volumising fillers (2 × STYLAGE Bi-Soft XL Lidocaine and 1 × STYLAGE XXL Mepivacaine) for lift and contour with intensive skin-revitalising gels (2 × STYLAGE Bi-Soft HydroMax) to improve hydration and dermal elasticity. Intended for use by trained aesthetic practitioners as a comprehensive course to restore structure and skin quality across multiple facial areas.
Bnefits
Combines volumisation and skin hydration for a comprehensive full-face rejuvenation approach
Volumising components (Bi-Soft XL and XXL Mepivacaine) provide projection and contouring for cheeks, jawline and chin
Cost-effective bundled supply for practitioners planning multi-product treatment protocols
Includes products formulated with Vivacy IPN-Like crosslinked HA technology and antioxidant excipients (mannitol or sorbitol) for gel stability
Indications
Restoration of facial volume and structural contouring (cheeks, chin, jawline, mandibular angle)
Improvement of skin hydration, elasticity and overall dermal quality for face, neck, décolleté and hands
Combination use in staged treatment protocols to address both volume loss and skin quality
Composition
STYLAGE Bi-Soft XL Lidocaine: cross-linked hyaluronic acid (HA) gel (Vivacy IPN-Like technology), mannitol antioxidant, lidocaine (in lidocaine variant); typical HA concentrations per product labeling (refer to IFU for exact mg/ml).
STYLAGE XXL Mepivacaine: cross-linked HA gel with mannitol and mepivacaine (local anaesthetic); reported strength ~21 mg/g HA and 3 mg/ml mepivacaine in distributor product specs.
STYLAGE Bi-Soft HydroMax: lightly cross-linked HA plus Sorbitol (Skin3 Complex) designed for hydration; typical concentration ~12.5 mg/ml (refer to product IFU for exact values).
Sterile, single-use pre-filled HA syringes in various rheology profiles (Bi-Soft technology) tailored for volumising (XL/XXL) or skin boosting (HydroMax).
Local anaesthetic variants include lidocaine or mepivacaine depending on the product presentation.
Packaging
Bundle contents (as listed by distributor example): 2 × STYLAGE Bi-Soft XL Lidocaine (2 × 1 ml syringes), 1 × STYLAGE XXL Mepivacaine (2 × 1 ml syringes), 2 × STYLAGE Bi-Soft HydroMax (1 ml syringes). Exact needle/cannula inclusions and box contents vary by distributor and market.
Usage
For professional use only — inject by certified medical practitioners experienced in dermal filler procedures.
Follow Vivacy Instructions for Use (IFU) for injection depth, volumes per session, recommended techniques for each product and area, and post-procedure care.
Perform full patient assessment, allergy/contraindication screening and obtain informed consent prior to treatment.
Maintain aseptic technique and be prepared to manage complications (have hyaluronidase and emergency protocols available).
Contraindications
Hypersensitivity to hyaluronic acid, local anaesthetics (lidocaine or mepivacaine where present), or any component of the formulations.
Active infection or inflammation at intended injection sites.
Pregnancy and breastfeeding (use not recommended — follow local labelling).
Patients with severe allergies or history of anaphylaxis should be assessed carefully before treatment.
Uncommon/rare: infection, persistent nodules or granulomatous reaction, vascular occlusion (may lead to skin necrosis), and very rare ocular complications if inadvertent intra-arterial injection occurs.
Follow manufacturer IFU and clinical protocols for recognition and management of complications (e.g., hyaluronidase administration for vascular compromise).
Storage Conditions
Store products as per each product IFU — typically controlled ambient conditions (commonly 2 °C to 25 °C); do not freeze; protect from excessive heat and direct sunlight; check expiry dates prior to use.
Duration
Durability varies by product and patient factors: volumising fillers (XL/XXL) commonly claim extended longevity (often up to 12\u201318 months depending on area and product), Hydromax effects on hydration are typically shorter-term and may be sustained with repeat treatments; refer to product IFUs for detail.
Onset
Immediate visual improvement is typically observed after injection; final settled result assessed after transient post-injection swelling subsides (hours to days).
